204 related articles for article (PubMed ID: 38040762)
1. Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8.
Sun D; Sun Y; Janezic E; Zhou T; Johnson M; Azumaya C; Noreng S; Chiu C; Seki A; Arenzana TL; Nicoludis JM; Shi Y; Wang B; Ho H; Joshi P; Tam C; Payandeh J; Comps-Agrar L; Wang J; Rutz S; Koerber JT; Masureel M
Nat Commun; 2023 Dec; 14(1):7940. PubMed ID: 38040762
[TBL] [Abstract][Full Text] [Related]
2. Biological characterization of ligands targeting the human CC chemokine receptor 8 (CCR8) reveals the biased signaling properties of small molecule agonists.
Liu L; Doijen J; D'huys T; Verhaegen Y; Dehaen W; De Jonghe S; Schols D; Van Loy T
Biochem Pharmacol; 2021 Jun; 188():114565. PubMed ID: 33872569
[TBL] [Abstract][Full Text] [Related]
3. Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion.
Haque NS; Fallon JT; Pan JJ; Taubman MB; Harpel PC
Blood; 2004 Feb; 103(4):1296-304. PubMed ID: 14576057
[TBL] [Abstract][Full Text] [Related]
4. Role of Conserved Disulfide Bridges and Aromatic Residues in Extracellular Loop 2 of Chemokine Receptor CCR8 for Chemokine and Small Molecule Binding.
Barington L; Rummel PC; Lückmann M; Pihl H; Larsen O; Daugvilaite V; Johnsen AH; Frimurer TM; Karlshøj S; Rosenkilde MM
J Biol Chem; 2016 Jul; 291(31):16208-20. PubMed ID: 27226537
[TBL] [Abstract][Full Text] [Related]
5. Structure/function relationships of CCR8 agonists and antagonists. Amino-terminal extension of CCL1 by a single amino acid generates a partial agonist.
Fox JM; Najarro P; Smith GL; Struyf S; Proost P; Pease JE
J Biol Chem; 2006 Dec; 281(48):36652-61. PubMed ID: 17023422
[TBL] [Abstract][Full Text] [Related]
6. Spinal CCL1/CCR8 signaling interplay as a potential therapeutic target - Evidence from a mouse diabetic neuropathy model.
Zychowska M; Rojewska E; Piotrowska A; Kreiner G; Nalepa I; Mika J
Int Immunopharmacol; 2017 Nov; 52():261-271. PubMed ID: 28961489
[TBL] [Abstract][Full Text] [Related]
7. The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium.
Haque NS; Fallon JT; Taubman MB; Harpel PC
Blood; 2001 Jan; 97(1):39-45. PubMed ID: 11133740
[TBL] [Abstract][Full Text] [Related]
8. CCR8-dependent activation of the RAS/MAPK pathway mediates anti-apoptotic activity of I-309/ CCL1 and vMIP-I.
Louahed J; Struyf S; Demoulin JB; Parmentier M; Van Snick J; Van Damme J; Renauld JC
Eur J Immunol; 2003 Feb; 33(2):494-501. PubMed ID: 12645948
[TBL] [Abstract][Full Text] [Related]
9. Identification of CCR8 as the specific receptor for the human beta-chemokine I-309: cloning and molecular characterization of murine CCR8 as the receptor for TCA-3.
Goya I; Gutiérrez J; Varona R; Kremer L; Zaballos A; Márquez G
J Immunol; 1998 Feb; 160(4):1975-81. PubMed ID: 9469461
[TBL] [Abstract][Full Text] [Related]
10. Molecular requirements for inhibition of the chemokine receptor CCR8--probe-dependent allosteric interactions.
Rummel PC; Arfelt KN; Baumann L; Jenkins TJ; Thiele S; Lüttichau HR; Johnsen A; Pease J; Ghosh S; Kolbeck R; Rosenkilde MM
Br J Pharmacol; 2012 Nov; 167(6):1206-17. PubMed ID: 22708643
[TBL] [Abstract][Full Text] [Related]
11. The chemokine receptor CCR8 mediates rescue from dexamethasone-induced apoptosis via an ERK-dependent pathway.
Spinetti G; Bernardini G; Camarda G; Mangoni A; Santoni A; Capogrossi MC; Napolitano M
J Leukoc Biol; 2003 Jan; 73(1):201-7. PubMed ID: 12525579
[TBL] [Abstract][Full Text] [Related]
12. CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation.
Gombert M; Dieu-Nosjean MC; Winterberg F; Bünemann E; Kubitza RC; Da Cunha L; Haahtela A; Lehtimäki S; Müller A; Rieker J; Meller S; Pivarcsi A; Koreck A; Fridman WH; Zentgraf HW; Pavenstädt H; Amara A; Caux C; Kemeny L; Alenius H; Lauerma A; Ruzicka T; Zlotnik A; Homey B
J Immunol; 2005 Apr; 174(8):5082-91. PubMed ID: 15814739
[TBL] [Abstract][Full Text] [Related]
13. Increased responsiveness of murine eosinophils to MIP-1beta (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8.
Oliveira SH; Lira S; Martinez-A C; Wiekowski M; Sullivan L; Lukacs NW
J Leukoc Biol; 2002 Jun; 71(6):1019-25. PubMed ID: 12050188
[TBL] [Abstract][Full Text] [Related]
14. Molecular interaction of a potent nonpeptide agonist with the chemokine receptor CCR8.
Jensen PC; Nygaard R; Thiele S; Elder A; Zhu G; Kolbeck R; Ghosh S; Schwartz TW; Rosenkilde MM
Mol Pharmacol; 2007 Aug; 72(2):327-40. PubMed ID: 17652183
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of CCL1-CCR8 interaction prevents aggregation of macrophages and development of peritoneal adhesions.
Hoshino A; Kawamura YI; Yasuhara M; Toyama-Sorimachi N; Yamamoto K; Matsukawa A; Lira SA; Dohi T
J Immunol; 2007 Apr; 178(8):5296-304. PubMed ID: 17404314
[TBL] [Abstract][Full Text] [Related]
16. Unveiling the structural mechanisms of nonpeptide ligand recognition and activation in human chemokine receptor CCR8.
Jiang S; Lin X; Wu L; Wang L; Wu Y; Xu Z; Xu F
Sci Adv; 2024 Feb; 10(5):eadj7500. PubMed ID: 38306437
[TBL] [Abstract][Full Text] [Related]
17. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells.
Iellem A; Mariani M; Lang R; Recalde H; Panina-Bordignon P; Sinigaglia F; D'Ambrosio D
J Exp Med; 2001 Sep; 194(6):847-53. PubMed ID: 11560999
[TBL] [Abstract][Full Text] [Related]
18. Identification of the CC chemokines TARC and macrophage inflammatory protein-1 beta as novel functional ligands for the CCR8 receptor.
Bernardini G; Hedrick J; Sozzani S; Luini W; Spinetti G; Weiss M; Menon S; Zlotnik A; Mantovani A; Santoni A; Napolitano M
Eur J Immunol; 1998 Feb; 28(2):582-8. PubMed ID: 9521068
[TBL] [Abstract][Full Text] [Related]
19. Coordinated involvement of mast cells and T cells in allergic mucosal inflammation: critical role of the CC chemokine ligand 1:CCR8 axis.
Gonzalo JA; Qiu Y; Lora JM; Al-Garawi A; Villeval JL; Boyce JA; Martinez-A C; Marquez G; Goya I; Hamid Q; Fraser CC; Picarella D; Cote-Sierra J; Hodge MR; Gutierrez-Ramos JC; Kolbeck R; Coyle AJ
J Immunol; 2007 Aug; 179(3):1740-50. PubMed ID: 17641040
[TBL] [Abstract][Full Text] [Related]
20. The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains.
Horuk R; Hesselgesser J; Zhou Y; Faulds D; Halks-Miller M; Harvey S; Taub D; Samson M; Parmentier M; Rucker J; Doranz BJ; Doms RW
J Biol Chem; 1998 Jan; 273(1):386-91. PubMed ID: 9417093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
